Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-06-23 10:33 Tx date 2025-04-19 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+350,000 vol |
350,000 | |
Filed 2025-04-24 16:29 Tx date 2025-04-19 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+350,000 vol |
||
Filed 2025-05-23 16:19 Tx date 2025-05-13 |
$NURL
Neural Therapeutics Inc. |
Ovadya, Eran
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
Filed 2025-05-23 16:18 Tx date 2024-12-16 |
$NURL
Neural Therapeutics Inc. |
Ovadya, Eran
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2025-04-24 16:29 Tx date 2025-04-19 |
$NRX
NurExone Biologic Inc formerly, EnerSpar Corp |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+350,000 vol |
350,000 | |
Filed 2024-05-24 16:04 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,062,500,000
+425,000 vol $42,500 each |
425,000 | |
Filed 2024-05-24 16:03 Tx date 2024-05-16 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-119,000
-425,000 vol $0.28 each |
0 | |
Filed 2023-05-09 18:02 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 18:01 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 18:00 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 17:59 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
||
Filed 2023-05-09 14:25 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+368,000 vol |
762,995 | |
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
||
Filed 2023-05-09 14:24 Tx date 2023-05-08 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+425,000 vol |
425,000 | |
Filed 2023-05-09 14:23 Tx date 2022-06-15 |
$NRX
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-06-23 11:12 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
394,995 | ||
Filed 2022-06-23 11:11 Tx date 2022-06-15 |
$ENER
NurExone Biologic Inc. (formerly, EnerSpar Corp.) |
Ovadya, Eran
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|